Lista de obras -

A placebo and active comparator-controlled trial of rofecoxib for the treatment of rheumatoid arthritis.

artículo científico publicado en 2002

An adolescent and adult formulation combined tetanus, diphtheria and five-component pertussis vaccine.

artículo científico publicado en 2006

Biochemical and biological characteristics of cross-reacting material 197 (CRM197), a non-toxic mutant of diphtheria toxin: Use as a conjugation protein in vaccines and other potential clinical applications ⬇️

artículo científico publicado el 28 de junio de 2011

Correlation between serum bactericidal activity against Neisseria meningitidis serogroups A, C, W-135 and Y measured using human versus rabbit serum as the complement source ⬇️

artículo científico publicado el 7 de noviembre de 2011

Critical appraisal of a quadrivalent CRM(197) conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo) in the context of treatment and prevention of invasive disease

artículo científico publicado en 2011

Early clinical experience with a candidate meningococcal B recombinant vaccine (rMenB) in healthy adults

artículo científico publicado en 2011

Experience with MCV-4, a meningococcal, diphtheria toxoid conjugate vaccine against serogroups A, C, Y and W-135.

artículo científico publicado en 2006

Ghostwriting in biomedicine: a review of the published literature

scientific article published on 22 May 2019

Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update

artículo científico publicado en 2022

Imported Human Rabies Cases in Europe, the United States, and Japan, 1990 to 2010: Table 1 ⬇️

artículo científico publicado el 4 de octubre de 2011

Increase of meningococcal serogroup Y cases in Europe: A reason for concern? ⬇️

artículo científico publicado el 1 de mayo de 2012

Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines

artículo científico publicado en 2012

Menveo®: a novel quadrivalent meningococcal CRM197conjugate vaccine against serogroups A, C, W-135 and Y ⬇️

artículo científico publicado el 1 de enero de 2011

Peer review in the global digital age: perspectives of publishing industry stakeholders

artículo científico publicado en 2023

Publication ethics from the ground up.

artículo científico publicado en 2018

Publication planning: promoting an ethics of transparency and integrity in biomedical research

artículo científico

Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritis.

artículo científico publicado en 2002

Rofecoxib shows consistent efficacy in osteoarthritis clinical trials, regardless of specific patient demographic and disease factors

artículo científico publicado el 1 de noviembre de 2001

Rofecoxib, a new cyclooxygenase 2 inhibitor, shows sustained efficacy, comparable with other nonsteroidal anti-inflammatory drugs: a 6-week and a 1-year trial in patients with osteoarthritis. Osteoarthritis Studies Group

artículo científico publicado en 2000

Statistical evaluations of the reproducibility and reliability of 3-tesla high resolution magnetization transfer brain images: a pilot study on healthy subjects.

artículo científico publicado en 2010

Substantial contribution and accountability: best authorship practices for medical writers in biomedical publications.

artículo científico publicado en 2018

The challenge of post-implementation surveillance for novel meningococcal vaccines.

artículo científico

The spectre of ghostwriting: eroding public trust in physicians, clinical trial integrity and biomedical authorship

artículo científico publicado en 2016

The sunshine act and medical publications: Guidance from professional medical associations.

artículo científico

Variability of genes encoding surface proteins used as vaccine antigens in meningococcal endemic and epidemic strain panels from Norway

artículo científico publicado en 2014

What is safety?: Miracles, benefit-risk assessments, and the "right to try".

artículo científico publicado en 2017

Lista de obras de

A placebo and active comparator-controlled trial of rofecoxib for the treatment of rheumatoid arthritis.

An adolescent and adult formulation combined tetanus, diphtheria and five-component pertussis vaccine.

Biochemical and biological characteristics of cross-reacting material 197 (CRM197), a non-toxic mutant of diphtheria toxin: Use as a conjugation protein in vaccines and other potential clinical applications ⬇️

Correlation between serum bactericidal activity against Neisseria meningitidis serogroups A, C, W-135 and Y measured using human versus rabbit serum as the complement source ⬇️

Critical appraisal of a quadrivalent CRM(197) conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo) in the context of treatment and prevention of invasive disease

Early clinical experience with a candidate meningococcal B recombinant vaccine (rMenB) in healthy adults

Experience with MCV-4, a meningococcal, diphtheria toxoid conjugate vaccine against serogroups A, C, Y and W-135.

Ghostwriting in biomedicine: a review of the published literature

Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update

Imported Human Rabies Cases in Europe, the United States, and Japan, 1990 to 2010: Table 1 ⬇️

Increase of meningococcal serogroup Y cases in Europe: A reason for concern? ⬇️

Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines

Menveo®: a novel quadrivalent meningococcal CRM197conjugate vaccine against serogroups A, C, W-135 and Y ⬇️

Peer review in the global digital age: perspectives of publishing industry stakeholders

Publication ethics from the ground up.

Publication planning: promoting an ethics of transparency and integrity in biomedical research

Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritis.

Rofecoxib shows consistent efficacy in osteoarthritis clinical trials, regardless of specific patient demographic and disease factors

Rofecoxib, a new cyclooxygenase 2 inhibitor, shows sustained efficacy, comparable with other nonsteroidal anti-inflammatory drugs: a 6-week and a 1-year trial in patients with osteoarthritis. Osteoarthritis Studies Group

Statistical evaluations of the reproducibility and reliability of 3-tesla high resolution magnetization transfer brain images: a pilot study on healthy subjects.

Substantial contribution and accountability: best authorship practices for medical writers in biomedical publications.

The challenge of post-implementation surveillance for novel meningococcal vaccines.

The spectre of ghostwriting: eroding public trust in physicians, clinical trial integrity and biomedical authorship

The sunshine act and medical publications: Guidance from professional medical associations.

Variability of genes encoding surface proteins used as vaccine antigens in meningococcal endemic and epidemic strain panels from Norway

What is safety?: Miracles, benefit-risk assessments, and the "right to try".